UGP2 and hepatocellular carcinoma: The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of UGP2 as a biomarker for the diagnosis of HCC were 56.3%, 94.1%, 98.6%, and 62.5%, respectively.